1. The interplay between viperin antiviral activity, lipid droplets and Junín mammarenavirus multiplication.
- Author
-
Peña Cárcamo JR, Morell ML, Vázquez CA, Vatansever S, Upadhyay AS, Överby AK, Cordo SM, and García CC
- Subjects
- Hemorrhagic Fever, American genetics, Hemorrhagic Fever, American virology, Humans, Interferons genetics, Interferons immunology, Junin virus chemistry, Junin virus genetics, Junin virus immunology, Lipid Droplets immunology, Nucleoproteins chemistry, Nucleoproteins genetics, Nucleoproteins immunology, Oxidoreductases Acting on CH-CH Group Donors, Protein Domains, Proteins chemistry, Proteins genetics, Virus Replication, Hemorrhagic Fever, American immunology, Junin virus physiology, Lipid Droplets virology, Proteins immunology
- Abstract
Junín arenavirus infections are associated with high levels of interferons in both severe and fatal cases. Upon Junín virus (JUNV) infection a cell signaling cascade initiates, that ultimately attempts to limit viral replication and prevent infection progression through the expression of host antiviral proteins. The interferon stimulated gene (ISG) viperin has drawn our attention as it has been highlighted as an important antiviral protein against several viral infections. The studies of the mechanistic actions of viperin have described important functional domains relating its antiviral and immune-modulating actions through cellular lipid structures. In line with this, through silencing and overexpression approaches, we have identified viperin as an antiviral ISG against JUNV. In addition, we found that lipid droplet structures are modulated during JUNV infection, suggesting its relevance for proper virus multiplication. Furthermore, our confocal microscopy images, bioinformatics and functional results also revealed viperin-JUNV protein interactions that might be participating in this antiviral pathway at lipid droplet level. Altogether, these results will help to better understand the factors mediating innate immunity in arenavirus infection and may lead to the development of pharmacological agents that can boost their effectiveness thereby leading to new treatments for this viral disease., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF